GS: Wall Street's Selloff Creates a Rare Entry Point
Key Takeaways
- Goldman Sachs trades at 15.3x trailing earnings after a 20% decline from its $984.70 high, with Q1 2026 earnings on April 13 as a near-term catalyst.
- Full-year 2025 EPS reached a record $51.32 on revenue of approximately $125 billion, demonstrating structural improvement in earnings quality.
- The $5.1 trillion global M&A backlog positions Goldman's investment banking franchise for continued strength despite near-term geopolitical headwinds.
- Book value of $400 per share and a 2.2x P/B ratio provide downside support, with the stock currently trading near its 200-day moving average.
Goldman Sachs shares have tumbled 20% from their $984.70 high, landing at $787.52 as the broader financial sector selloff sweeps through Wall Street. The stock dropped another 4.4% today on elevated volume of 3.1 million shares — well above the 2.4 million daily average. Fear is doing the pricing here, not fundamentals.
The market is treating Goldman like a leveraged bet on risk appetite, and right now risk appetite is in short supply. The Iran conflict has rattled investor confidence, private credit concerns are mounting, and retail investors are showing persistent fatigue. But strip away the macro noise and what remains is a franchise that just posted $51.32 in earnings per share across 2025 — a record year — trading at 15.3x earnings. That is not expensive for the dominant name in investment banking and trading.
With Q1 2026 earnings due April 13, a global M&A backlog exceeding $5.1 trillion, and the stock now sitting below its 200-day moving average of $792, the question is simple: is this a correction you buy, or a breakdown you avoid?
Valuation: The Numbers Don't Support the Panic
Goldman trades at a P/E of 15.3x on trailing earnings of $51.32 — well below its 2025 average multiple and below the S&P 500 and comparable to JPMorgan's current valuation. The price-to-book ratio sits at 2.2x against a book value of roughly $400 per share, which is reasonable for a bank generating mid-teens ROE.
The stock's 52-week range tells the story of a dramatic reversal: from a low of $439.38 to a high of $984.70, Goldman rallied 53.5% in 2025 before giving back a significant chunk. At $787.52, you're buying the stock at essentially its 200-day moving average — a technical level that has historically provided support.
Enterprise value to EBITDA appears elevated at 113x, but this metric is misleading for banks where interest expense distorts the calculation. Focus instead on P/E and P/B, both of which signal fair to slightly cheap valuation for a franchise of this quality.
Earnings: A Record Year Nobody Remembers
Goldman's 2025 was a powerhouse year. Quarterly EPS came in at $14.12 (Q1), $10.95 (Q2), $12.25 (Q3), and $14.00 (Q4), delivering full-year diluted EPS of $51.32. Revenue ranged from $30.1 billion to $32.2 billion per quarter, totalling approximately $125 billion for the year.
Q4 2025 revenue of $30.1 billion included gross profit of $15.6 billion — a gross margin of 51.7%. Operating income reached $5.9 billion with a 19.4% operating margin. Net income of $4.6 billion represented a 15.3% net margin, with an effective tax rate of 21.1%.
The key trend: Goldman's revenue base has structurally expanded. This is no longer a firm that swings wildly between $20 billion and $40 billion in annual revenue. The combination of a resurgent investment banking franchise and a maturing asset management business has created more predictable earnings.
Financial Health: The Fortress You'd Expect
Goldman's balance sheet carries the leverage typical of a global investment bank. Debt-to-equity stands at 4.9x with total interest-bearing debt around $2,003 per share — large in absolute terms but manageable given the asset base. Book value per share of $400 and tangible book of $378 provide meaningful downside support.
The dividend, while modest at a 0.53% yield, represents a 32% payout ratio — conservative enough to fund buybacks and strategic investments while returning capital. Goldman repurchased shares aggressively in 2025, reducing the diluted share count from 324.5 million in Q1 to 317.6 million in Q4.
Free cash flow is lumpy for Goldman, as is typical for investment banks where working capital swings with trading positions. Q2 2025 generated $16.56 per share in FCF while Q4 showed negative FCF. Over a full cycle, the firm is a consistent cash generator.
Growth: M&A Supercycle Meets AI Opportunity
The investment banking pipeline remains Goldman's most compelling growth driver. Global M&A volumes hit $5.1 trillion in 2025, and the backlog heading into 2026 is substantial. Goldman's advisory and underwriting franchises are the best in the business, and deal activity tends to accelerate when volatility settles — meaning the current pullback may be creating pent-up demand.
Goldman's AI initiatives and private-market expansion represent longer-term growth vectors. The firm is aggressively building its alternatives platform, competing with the likes of Blackstone and KKR for institutional capital. However, recent Benzinga reporting noted that some Goldman clients are "glad" the Iran conflict has shifted attention away from software exposure and private credit concerns — a candid admission that parts of the book face headwinds.
Analyst estimates project continued revenue growth, with forward estimates averaging $17-18 billion per quarter on a reported basis. The market is pricing in near-zero growth, which creates asymmetric upside if deal activity meets even modest expectations.
Forward Outlook: April Earnings as Catalyst
Goldman reports Q1 2026 earnings on April 13, making this a catalyst-rich setup. The street will be watching for three things: investment banking revenue (has the M&A pipeline converted?), trading revenue (has volatility helped or hurt?), and commentary on credit quality in the alternatives book.
The Iran conflict creates a paradoxical backdrop. Elevated geopolitical volatility typically boosts trading revenue — Goldman's FICC and equities desks tend to outperform in choppy markets. At the same time, it suppresses deal activity and dampens risk sentiment that supports asset management flows.
The consensus appears to be that Goldman's 53.5% rally in 2025 was overdone and the stock needs to consolidate. But at 15x earnings with a clear catalyst on the horizon, the risk-reward skews bullish from current levels. This is not a stock that should trade below book value unless you expect a recession — and the data doesn't support that conclusion yet.
Conclusion
The selloff in Goldman Sachs looks like a classic case of throwing the baby out with the bathwater. The stock is down 20% from its highs on macro fears that are real but priced in. At $787.52, you're paying 15x earnings for the premier investment banking franchise during what is still the early innings of an M&A supercycle.
The bear case — that private credit exposure is a ticking time bomb and the Iran conflict will derail capital markets — deserves monitoring but not panic selling. Goldman's balance sheet is solid, earnings are at record levels, and April earnings provide a near-term catalyst. For investors with a 12-month horizon, this pullback is an entry point you rarely get with Goldman Sachs.
Frequently Asked Questions
Sources & References
seekingalpha.com
Disclaimer: This content is for informational purposes only and does not constitute financial advice. Consult qualified professionals before making investment decisions.